Skip to main content

Alector, Inc.

ALEC
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001653087

In the last 90 days, Alector, Inc. insiders filed 0 open-market purchases and 3 sales; 140 institutions reported holding it in 13F filings for Q2 2026, worth $183.4M in total; no superinvestor holds it.

Q2 2025 vs. Q1 2025

How the institutions holding Alector, Inc. changed between Q1 2025 and Q2 2025.

All holders in Q2 2025All holders in Q1 2025

13F holders of ALEC: Q1 2025 compared with Q2 2025
MeasureQ1 2025Q2 2025Change
Holders141136−5
Shares72.6M70.5M−2.11M (−2.9%)
Value$89.1M$98.7M+$9.57M (+10.7%)

New holders (17)

Institutions that held Alector, Inc. at the end of Q2 2025 but not at the end of Q1 2025.

Institutions new to ALEC in Q2 2025
InstitutionSharesValue% of portfolio
Mackenzie Financial Corp274,442$384.2K0.00%
Gsa Capital Partners LLP150,669$211.0K0.01%
Bridgeway Capital Management, LLC115,000$161.0K0.00%
Bank of Montreal52,380$73.3K0.00%
Cubist Systematic Strategies, LLC21,819$30.5K0.00%
Prudential Financial Inc21,322$29.9K0.00%
Public Employees Retirement System of Ohio7,900$11.1K0.00%
Raymond James Financial Inc1,479$2.07K0.00%
Hughes Financial Services, LLC929$1.33K0.00%
Skopos Labs, Inc.601$8420.00%
Essential Partners LLC444$6220.00%
Fortitude Family Office, LLC439$6150.00%
Rise Advisors, LLC407$5700.00%
Clearstead Advisors, LLC323$4530.00%
Allworth Financial LP200$2800.00%
IFP Advisors, Inc9$130.00%
Truvestments Capital LLC2$30.00%

Sold out (22)

Institutions that held Alector, Inc. at the end of Q1 2025 and filed for Q2 2025 without it.